Aton (EPA:ALTAO)

Market Cap	13.42M +105.6%
Revenue (ttm)	661.00K +7.7%
Net Income	-962.00K
EPS	-0.00
Shares Out	828.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,702,991
Open	0.0162
Previous Close	0.0162
Day's Range	0.0154 - 0.0166
52-Week Range	0.0050 - 0.0290
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTAO

Financial Performance

In 2025, Aton's revenue was 661,000, an increase of 7.65% compared to the previous year's 614,000. Losses were -962,000, -12.62% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 31, 2026

Data Sources Report a data error